These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8440266)

  • 1. Indium-111-labelled liposomes: dosimetry and tumour detection in patients with cancer.
    Kubo A; Nakamura K; Sammiya T; Katayama M; Hashimoto T; Hashimoto S; Kobayashi H; Teramoto T
    Eur J Nucl Med; 1993 Feb; 20(2):107-13. PubMed ID: 8440266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-111-labeled liposomes: dosimetry and tumor depiction.
    Turner AF; Presant CA; Proffitt RT; Williams LE; Winsor DW; Werner JL
    Radiology; 1988 Mar; 166(3):761-5. PubMed ID: 3340774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamic distribution and dosimetric evaluation of human non-specific immunoglobulin G labelled with 111In or 99Tcm.
    Buijs WC; Oyen WJ; Dams ET; Boerman OC; Siegel JA; Claessens RA; van der Meer JW; Corstens FH
    Nucl Med Commun; 1998 Aug; 19(8):743-51. PubMed ID: 9751928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiation dose from human platelets labelled with indium 111.
    van Reenen OR; Lötter MG; Minnaar PC; Heyns Adu P; Badenhorst PN; Pieters H
    Br J Radiol; 1980 Aug; 53(632):790-5. PubMed ID: 6777011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 111In-oxine-labelled granulocyte dosimetry in normal subjects.
    Forstrom LA; Dunn WL; Rowe FA; Camilleri M
    Nucl Med Commun; 1995 May; 16(5):349-56. PubMed ID: 7659387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indium-111-DOTA-lanreotide: biodistribution, safety and radiation absorbed dose in tumor patients.
    Virgolini I; Szilvasi I; Kurtaran A; Angelberger P; Raderer M; Havlik E; Vorbeck F; Bischof C; Leimer M; Dorner G; Kletter K; Niederle B; Scheithauer W; Smith-Jones P
    J Nucl Med; 1998 Nov; 39(11):1928-36. PubMed ID: 9829585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation absorbed dose from indium-111-CYT-356.
    Mardirossian G; Brill AB; Dwyer KM; Kahn D; Nelp W
    J Nucl Med; 1996 Sep; 37(9):1583-8. PubMed ID: 8790224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and dosimetry of [111In] F(ab')2 fragments against prostatic acid phosphatase after intraprostatic injection for immunoscintigraphy in prostate cancer.
    Nielsen JT; Poulsen J; Flø C; Marqversen J; Rehling M
    Clin Physiol; 1995 Sep; 15(5):467-81. PubMed ID: 8846667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoclonal antibody BW431/26 labelled with technetium 99m and indium 111: an investigation of the biodistribution and the dosimetry in patients.
    Benz P; Oberhausen E; Berberich R
    Eur J Nucl Med; 1991; 18(10):813-6. PubMed ID: 1743204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dosimetric evaluation of immunoscintigraphy using indium-111-labeled monoclonal antibody fragments in patients with ovarian cancer.
    Buijs WC; Massuger LF; Claessens RA; Kenemans P; Corstens FH
    J Nucl Med; 1992 Jun; 33(6):1113-20. PubMed ID: 1597725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. I. The effect on image contrast in clinical studies.
    Perkins AC; Pimm MV
    Eur J Nucl Med; 1985; 11(8):295-9. PubMed ID: 4076237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liposomal distribution in malignant glioma: possibilities for therapy.
    Khalifa A; Dodds D; Rampling R; Paterson J; Murray T
    Nucl Med Commun; 1997 Jan; 18(1):17-23. PubMed ID: 9061696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary lung cancer: biodistribution and dosimetry of two In-111-labeled monoclonal antibodies.
    Brown PH; Krishnamurthy GT; Turner FE; Denney RK; Gilbert SA; Slauson ME
    Radiology; 1989 Dec; 173(3):701-5. PubMed ID: 2510212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful imaging of human cancer with indium-111-labeled phospholipid vesicles.
    Presant CA; Proffitt RT; Turner AF; Williams LE; Winsor D; Werner JL; Kennedy P; Wiseman C; Gala K; McKenna RJ
    Cancer; 1988 Sep; 62(5):905-11. PubMed ID: 3409173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human radiation dosimetry of [11C]MeAIB, a new tracer for imaging of system A amino acid transport.
    Tolvanen T; Någren K; Yu M; Sutinen E; Havu-Aurén K; Jyrkkiö S; Asola M; Kotoneva E; Nuutila P; Minn H
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1178-84. PubMed ID: 16721566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts.
    Pimm MV; Perkins AC; Baldwin RW
    Eur J Nucl Med; 1985; 11(8):300-4. PubMed ID: 4076238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced accumulation of long-circulating liposomes modified with the nucleosome-specific monoclonal antibody 2C5 in various tumours in mice: gamma-imaging studies.
    Elbayoumi TA; Torchilin VP
    Eur J Nucl Med Mol Imaging; 2006 Oct; 33(10):1196-205. PubMed ID: 16763815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rituximab treatment on (90)Y-ibritumomab dosimetry for patients with non-Hodgkin lymphoma.
    Shen S; Forero A; Meredith RF; Shah JJ; Knox SJ; Wiseman GA; Usrey ME; Lobuglio AF
    J Nucl Med; 2010 Jan; 51(1):150-7. PubMed ID: 20008989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pre-therapeutic dosimetry and biodistribution of 86Y-DOTA-Phe1-Tyr3-octreotide versus 111In-pentetreotide in patients with advanced neuroendocrine tumours.
    Helisch A; Förster GJ; Reber H; Buchholz HG; Arnold R; Göke B; Weber MM; Wiedenmann B; Pauwels S; Haus U; Bouterfa H; Bartenstein P
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1386-92. PubMed ID: 15175836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies.
    Harrington KJ; Rowlinson-Busza G; Syrigos KN; Uster PS; Abra RM; Stewart JS
    Br J Cancer; 2000 Jul; 83(2):232-8. PubMed ID: 10901376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.